Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Re-Evaluating the Inhibition of Stress Erosions (GI Bleeding Prophylaxis in ICU)
2020-000483-27Phase 3Unknown
- Sponsor
- St. Joseph's Healthcare Hamilton
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Acute Stress Gastritis, upper gastrointestinal bleeding (UGIB), gastrointestinal conditions and 1 more comparing Pantoprazole IV with Placebo IV (2 arms). Primary endpoint: Clinically important gastrointestinal bleeding in ICU or leading to ICU readmission. Status: unknown.
02
Drugs
pantoprazole
03
Conditions
Acute Stress Gastritisupper gastrointestinal bleeding (UGIB)gastrointestinal conditionscritical illness
Beyond the preview
Go deeper on 2020-000483-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000483-27.